Health
New study charts the complexity of SARS-CoV-2 neutralization – EurekAlert
In the absence of effective treatments for COVID-19, many countries have approved the therapeutic use of blood plasma from recovering patients because it contains…
Washington, DC – February 24, 2021 – In the absence of effective treatments for COVID-19, many countries have approved the therapeutic use of blood plasma from recovering patients because it contains antibodies against the coronavirus. But not every type of antibody can neutralize the virus and render it noninfectious. New research published this week in mSphere, an open-access journal of the American Society for Microbiology, explores variation in virus neutralization capabilities, which can vary…
-
Noosa News8 hours agoConsolidated Pastoral Company buys Beetaloo aggregation in historic deal worth more than $300m
-
General23 hours agoAnthony Albanese condemns Bondi Beach terror attack as ‘act of evil antisemitism’
-
General23 hours agoThe mysterious assailants at Bondi
-
Business19 hours agoWhat Warren Buffett’s latest portfolio moves say about the market